COVID-19 Pandemic The impact of the COVID-19 pandemic has demonstrated FDOH-Escambia’s continued commitment to public health. FDOH-Escambia staff have had and continue to have an important role in keeping the public safe and healthy amid the COVID-19 pandemic. Below is a snapshot of how the pandemic progressed and FDOHEscambia’s response to COVID-19 in our community.
Pictured Right: FDOH-Escambia employees participate in the COVID vaccine POD at Brownsville on February 24, 2021 The FDA grants emergency use authorization to Johnson & Johnson’s COVID-19 vaccine, the first single dose COVID-19 vaccine available in the US. CDC recommends pausing the use of the Johnson and Johnson COVID-19 vaccine because of blood clot complications.
FDA approves emergency use authorization for Johnson and Johnson one shot COVID-19 vaccine
February
2020
27
April
2020
13
23
The Delta variant, first identified in India in late 2020, becomes the dominant variant in the U.S. The variant kicks off a third wave of infections during the summer of 2021.
June
2020
CDC recommends continued use of Johnson and Johnson vaccine for people 18 and older.
Pictured Left: COVID-19 Vaccines
3
1
The US FDA grants full approval to the Pfizer/BioNTech COVID-19 vaccine for people age 16 and older
August
2020
12
23
The FDA authorizes an additional COVID-19 vaccine dose for certain immunocompromised people.
